Skip to main content
Log in

Anakinra/canakinumab

Various toxicities: 19 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Babaoglu H, et al. Effectiveness of canakinumab in colchicine- and anakinra-resistant or -intolerant adult familial mediterranean fever patients: A single-center real-life study. JCR: Journal of Clinical Rheumatology 26: 7-13, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1097/RHU.0000000000000873

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anakinra/canakinumab. Reactions Weekly 1791, 27 (2020). https://doi.org/10.1007/s40278-020-74872-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74872-3

Navigation